Accepted at 1:16 a.m. Nov, 01, 2023 by dollajas
Author: boma17
Related Note: 1514737162457
Rationale for change

6 months ---> "12 weeks"

"ANTIVIRAL THERAPY

Goals of therapy — The goal of antiviral therapy in patients with chronic hepatitis C virus (HCV) is to eradicate HCV RNA, which is predicted by attainment of a sustained virologic response (SVR), defined as an undetectable RNA level 12 weeks following the completion of therapy."

source: uptodate
(https://www.uptodate.com/contents/overview-of-the-management-of-chronic-hepatitis-c-virus-infection?search=sustained%20virologic%20response&source=search_result&selectedTitle=1~54&usage_type=default&display_rank=1)

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Sketchy 2
Empty field
Sketchy Extra


Watch Hepatitis C: Direct-Acting Antivirals (DAAs)
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Positive-sense RNA Viruses : Hepatitis C Part 2 (Diagnostics and Management)
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::07_Antimicrobials::07_Other_Antivirals::02_Hepatitis_C_Direct-Acting_Antivirals_(DAAs) !AK_UpdateTags::AnKing_Image::MS::HCV_management !AK_UpdateTags::AnKing_Image::Mujeeb::HCV_management #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Bootcamp::Microbiology::28_Positive-sense_RNA_Viruses::14_Hepatitis_C_Part_2_(Diagnostics_and_Management) #AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::GI::hepatic_disorders #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::04_Ribavirin,_Sofosbuvir,_Simeprevir_[Retired_Video] #AK_Step1_v12::#Physeo::09_Pharm::02_Antivirals::10_Hepatitis_C_Therapy #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::51_Hepatitis_C_therapy #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_3::Viruses::Antiviral_Medications #PANCE::EOR::Family_med #PANCE::EOR::IM